Cargando…
KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
Interactions of KRAB (Krüppel-associated box)-associated protein KAP1 [also known as TRIM28 (tripartite motif containing protein 28)] with DNA-binding KRAB zinc finger (KRAB-ZF) proteins silence many transposable elements during embryogenesis. However, in some cancers, TRIM28 is upregulated and inte...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380489/ https://www.ncbi.nlm.nih.gov/pubmed/32743551 http://dx.doi.org/10.1093/narcan/zcaa007 |
_version_ | 1783562864031694848 |
---|---|
author | Kumar, Janani Kaur, Gundeep Ren, Ren Lu, Yue Lin, Kevin Li, Jia Huang, Yun Patel, Anamika Barton, Michelle C Macfarlan, Todd Zhang, Xing Cheng, Xiaodong |
author_facet | Kumar, Janani Kaur, Gundeep Ren, Ren Lu, Yue Lin, Kevin Li, Jia Huang, Yun Patel, Anamika Barton, Michelle C Macfarlan, Todd Zhang, Xing Cheng, Xiaodong |
author_sort | Kumar, Janani |
collection | PubMed |
description | Interactions of KRAB (Krüppel-associated box)-associated protein KAP1 [also known as TRIM28 (tripartite motif containing protein 28)] with DNA-binding KRAB zinc finger (KRAB-ZF) proteins silence many transposable elements during embryogenesis. However, in some cancers, TRIM28 is upregulated and interacts with different partners, many of which are transcription regulators such as EZH2 in MCF7 cells, to form abnormal repressive or activating complexes that lead to misregulation of genes. We ask whether a KRAB domain—the TRIM28 interaction domain present in native binding partners of TRIM28 that mediate repression of transposable elements—could be used as a tool molecule to disrupt aberrant TRIM28 complexes. Expression of KRAB domain containing fragments from a KRAB-ZF protein (ZFP568) in MCF7 cells, without the DNA-binding zinc fingers, inhibited TRIM28–EZH2 interactions and caused degradation of both TRIM28 and EZH2 proteins as well as other components of the EZH2-associated polycomb repressor 2 complex. In consequence, the product of EZH2 enzymatic activity, trimethylation of histone H3 lysine 27 level, was significantly reduced. The expression of a synthetic KRAB domain significantly inhibits the growth of breast cancer cells (MCF7) but has no effect on normal (immortalized) human mammary epithelial cells (MCF10a). Further, we found that TRIM28 is a positive regulator of TRIM24 protein levels, as observed previously in prostate cancer cells, and expression of the KRAB domain also lowered TRIM24 protein. Importantly, reduction of TRIM24 levels, by treatment with either the KRAB domain or a small-molecule degrader targeted to TRIM24, is accompanied by an elevated level of tumor suppressor p53. Taken together, this study reveals a novel mechanism for a TRIM28-associated protein stability network and establishes TRIM28 as a potential therapeutic target in cancers where TRIM28 is elevated. Finally, we discuss a potential mechanism of KRAB-ZF gene expression controlled by a regulatory feedback loop of TRIM28–KRAB. |
format | Online Article Text |
id | pubmed-7380489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-73804892020-07-29 KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells Kumar, Janani Kaur, Gundeep Ren, Ren Lu, Yue Lin, Kevin Li, Jia Huang, Yun Patel, Anamika Barton, Michelle C Macfarlan, Todd Zhang, Xing Cheng, Xiaodong NAR Cancer Cancer Gene Regulation, Chromatin, and Epigenetics Interactions of KRAB (Krüppel-associated box)-associated protein KAP1 [also known as TRIM28 (tripartite motif containing protein 28)] with DNA-binding KRAB zinc finger (KRAB-ZF) proteins silence many transposable elements during embryogenesis. However, in some cancers, TRIM28 is upregulated and interacts with different partners, many of which are transcription regulators such as EZH2 in MCF7 cells, to form abnormal repressive or activating complexes that lead to misregulation of genes. We ask whether a KRAB domain—the TRIM28 interaction domain present in native binding partners of TRIM28 that mediate repression of transposable elements—could be used as a tool molecule to disrupt aberrant TRIM28 complexes. Expression of KRAB domain containing fragments from a KRAB-ZF protein (ZFP568) in MCF7 cells, without the DNA-binding zinc fingers, inhibited TRIM28–EZH2 interactions and caused degradation of both TRIM28 and EZH2 proteins as well as other components of the EZH2-associated polycomb repressor 2 complex. In consequence, the product of EZH2 enzymatic activity, trimethylation of histone H3 lysine 27 level, was significantly reduced. The expression of a synthetic KRAB domain significantly inhibits the growth of breast cancer cells (MCF7) but has no effect on normal (immortalized) human mammary epithelial cells (MCF10a). Further, we found that TRIM28 is a positive regulator of TRIM24 protein levels, as observed previously in prostate cancer cells, and expression of the KRAB domain also lowered TRIM24 protein. Importantly, reduction of TRIM24 levels, by treatment with either the KRAB domain or a small-molecule degrader targeted to TRIM24, is accompanied by an elevated level of tumor suppressor p53. Taken together, this study reveals a novel mechanism for a TRIM28-associated protein stability network and establishes TRIM28 as a potential therapeutic target in cancers where TRIM28 is elevated. Finally, we discuss a potential mechanism of KRAB-ZF gene expression controlled by a regulatory feedback loop of TRIM28–KRAB. Oxford University Press 2020-05-18 /pmc/articles/PMC7380489/ /pubmed/32743551 http://dx.doi.org/10.1093/narcan/zcaa007 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Cancer Gene Regulation, Chromatin, and Epigenetics Kumar, Janani Kaur, Gundeep Ren, Ren Lu, Yue Lin, Kevin Li, Jia Huang, Yun Patel, Anamika Barton, Michelle C Macfarlan, Todd Zhang, Xing Cheng, Xiaodong KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells |
title | KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells |
title_full | KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells |
title_fullStr | KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells |
title_full_unstemmed | KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells |
title_short | KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells |
title_sort | krab domain of zfp568 disrupts trim28-mediated abnormal interactions in cancer cells |
topic | Cancer Gene Regulation, Chromatin, and Epigenetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380489/ https://www.ncbi.nlm.nih.gov/pubmed/32743551 http://dx.doi.org/10.1093/narcan/zcaa007 |
work_keys_str_mv | AT kumarjanani krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT kaurgundeep krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT renren krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT luyue krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT linkevin krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT lijia krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT huangyun krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT patelanamika krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT bartonmichellec krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT macfarlantodd krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT zhangxing krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells AT chengxiaodong krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells |